发明名称 Compositions and Methods for Inhibiting Expression of the PCSK9 Gene
摘要 The invention relates to a double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of the PCSK9 gene (PCSK9 gene), comprising an antisense strand having a nucleotide sequence which is less that 30 nucleotides in length, generally 19-25 nucleotides in length, and which is substantially complementary to at least a part of the PCSK9 gene. The invention also relates to a pharmaceutical composition comprising the dsRNA together with a pharmaceutically acceptable carrier and method for treating diseases caused by PCSK9 gene expression.
申请公布号 US2014350075(A1) 申请公布日期 2014.11.27
申请号 US201414330923 申请日期 2014.07.14
申请人 Alnylam Pharmaceuticals, Inc. 发明人 Tan Pamela;Bramlage Birgit;Frank-Kamenetsky Maria;Fitzgerald Kevin;Akinc Akin;Kotelianski Victor
分类号 C12N15/113 主分类号 C12N15/113
代理机构 代理人
主权项 1. A double-stranded ribonucleic acid (dsRNA) for inhibiting expression of a human proprotein convertase subtilisin kexin 9 (PCSK9) gene in a cell, wherein the dsRNA comprises a sense strand and an antisense strand complementary to at least 15 contiguous nucleotides of a PCSK9 gene and comprises a duplex structure between 15 and 30 base pairs in length.
地址 Cambridge MA US